ANTIPHOSPHOLIPID ANTIBODIES
1990; Wiley; Volume: 74; Issue: 1 Linguagem: Inglês
10.1111/j.1365-2141.1988.00491.x-i1
ISSN1365-2141
Autores Tópico(s)Autoimmune and Inflammatory Disorders Research
ResumoBritish Journal of HaematologyVolume 74, Issue 1 p. 1-9 ANTIPHOSPHOLIPID ANTIBODIES E. Nigel Harris, Corresponding Author E. Nigel Harris Department of Medicine, University of LouisvilleDr E. Nigel Harris, Department of Medicine, University of Louisville, Louisville, Kentucky 40292, U.S.A.Search for more papers by this author E. Nigel Harris, Corresponding Author E. Nigel Harris Department of Medicine, University of LouisvilleDr E. Nigel Harris, Department of Medicine, University of Louisville, Louisville, Kentucky 40292, U.S.A.Search for more papers by this author First published: January 1990 https://doi.org/10.1111/j.1365-2141.1988.00491.x-i1Citations: 61AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References Alving, C. (1977) Immune reactions of lipids and lipid model membranes. The Antigens (ed. by M. Sela), Vol. 4, pp. 1 – 15. Academic Press, New York . 10.1016/B978-0-12-635504-8.50007-9 Google Scholar Alving, C.R. (1986) Antibodies to liposomes, phospholipids, and phosphate esters. Chemistry and Physics of Lipids, 40, 303 – 314. 10.1016/0009-3084(86)90075-7 CASPubMedWeb of Science®Google Scholar Alving, B.M., Baldwin, P.E., Richard, R.L. & Jackson, B.J. (1985) The dilute phospholipid APTT: a sensitive test for verification of lupus anticoagulants. Thrombosis and Haemostasis, 54, 709 – 712. CASPubMedWeb of Science®Google Scholar Angeles-Cano, E., Sultan, Y. & Clauvel, J.P. (1979) Predisposing factors to thrombosis in systemic lupus erythematosus: possible relation to endothelial cell damage. Journal of Laboratory and Clinical Medicine, 94, 313 – 323. Google Scholar Asherson, R.A., Chan, J.K.H., Harris, E.N. & Gharavi, A.E. (1985) Anti-cardiolipin antibody, recurrent thrombosis, and warfarin withdrawal. Annals of Rheumatic Disease, 44, 823 – 825. 10.1136/ard.44.12.823 CASPubMedWeb of Science®Google Scholar Bowie, W.E.J., Thompson, J.H., Pascuzzi, C.A. & Owen, G.A. (1963) Thrombosis in systemic lupus erythematosus despite circulating anticoagulants. Journal of Clinical Investigation, 62, 416 – 430. PubMedWeb of Science®Google Scholar Branch, W.D. (1987) Immunologic disease and fetal death. Clinical Obstetrics and Gynecology, 30, 295 – 311. 10.1097/00003081-198706000-00009 CASPubMedWeb of Science®Google Scholar Branch, W.D., Dudley, D.J., Daynes, R., Mitchell, M.D. & Abbott, J.M. (1989) IgG fractions from patients with anti-phospholipid antibodies cause fetal death in BALB/C mice: a new model for autoimmune abortion. (Abstract). Proceedings of the Society of Gynecological Investigation, 36th Annual Meeting, March 15--17, 1989. Google Scholar Canoso, R.T. & Sise, H.S. (1982) Chlorpromazine-induced lupus anticoagulant and associated immunological abnormalities. American Journal of Hematology, 13, 121 – 129. 10.1002/ajh.2830130204 CASPubMedWeb of Science®Google Scholar Cariou, R., Tobelin, G., Bellucci, S., Soria, J., Soria, C., Maclouf, J. & Caen, J. (1985) Effect of the lupus anticoagulant on antithrombogenic properties of endothelial cells---inhibition of thrombomodulin dependent protein C activation. Thrombosis and Haemostasis, 60, 54 – 58. Google Scholar Carreras, L.O., Machin, S.J., Deman, R., Defreyn, G., Vermylen, J., Spitz, B. & Van Assche, A. (1981) Arterial thrombosis, intrauterine death and 'lupus anticoagulant': detection of immunoglobulin interfering with prostacylin formation. Lancet, i, 244 – 246. 10.1016/S0140-6736(81)92087-0 CASGoogle Scholar Catterall, R.D. (1973) Biological false positive reactions and systemic disease. Ninth Symposium on Advanced Medicine (ed. by G. Walker), pp. 97 – 111. Pitman Medical, London . Google Scholar Colaco, C.B. & Male, D.K. (1985) Anti-phospholipid antibodies in syphilis and a thrombotic subset of SLE: distinct profiles of epitope specificities. Clinical and Experimental Immunology, 59, 449 – 456. CASPubMedWeb of Science®Google Scholar Comp, P.C., De Bault, L.E., Esmon, N.L. & Esmon, C.T. (1983) Human thrombomodulin is inhibited by IgG from two patients with nonspecific anticoagulants. (Abstract). Blood, 62, (Supplement 1), 299a. Google Scholar Cowchock, S., Fort, J., Munoz, S., Norberg, R. & Maddey, W. (1988) False positive ELISA tests for anti-cardiolipin antibodies in sera from patients with repeated abortion, rheumatologic disorders and primary biliary cirrhosis: correlation with elevated polyclonal IgM and implication for patients with repeated abortion. Clinical and Experimental Immunology, 73, 289 – 294. CASPubMedWeb of Science®Google Scholar Derksen, R.H.W.M., Biesma, D. & Bouma, B.N. (1986) Discordant effects of prednisone on anti-cardiolipin antibodies and the lupus anticoagulant. Arthritis and Rheumatism, 29, 1295 – 1296. 10.1002/art.1780291021 CASPubMedWeb of Science®Google Scholar Derksen, R.H.W.M., Hasselaar, P., Blokzijl, L., Meyling, F.H.J.G. & DeGroot, P.G. (1988) Coagulation screen is more specific than the anti-cardiolipin antibody ELISA in defining a thrombotic subset of lupus patients. Annals of Rheumatic Disease, 47, 364 – 371. 10.1136/ard.47.5.364 CASPubMedWeb of Science®Google Scholar Exner, T., Rickard, K.A. & Kronenberg, H. (1975) Studies on phospholipids in the action of lupus anticoagulant inhibitor. Pathology, 7, 319 – 328. 10.3109/00313027509081688 CASPubMedWeb of Science®Google Scholar Exner, T., Sahman, N. & Trudinger, B. (1988) Separation of anti-cardiolipin antibodies from lupus anticoagulant on a phospholipid coated polystyrene column. Biochemical and Biophysical Research Communications, 155, 1001 – 1007. 10.1016/S0006-291X(88)80596-5 CASPubMedWeb of Science®Google Scholar Firkin, B.G., Booth, P., Hendrix, I. & Howard, M.A. (1978) Demonstration of a platelet bypass mechanism in the clotting system using an acquired anticoagulant. American Journal of Hematology, 5, 81 – 92. 10.1002/ajh.2830050202 CASPubMedWeb of Science®Google Scholar Firkin, B.G., Howard, M.A. & Radford, N. (1980) Possible relationship between lupus inhibitor and recurrent abortion in young women. Lancet, ii, 366. 10.1016/S0140-6736(80)90361-X CASGoogle Scholar Fiumara, N.S. (1963) Biological false-positive reaction for syphilis. New England Journal of Medicine, 268, 402 – 405. 10.1056/NEJM196302212680802 CASPubMedWeb of Science®Google Scholar Fleck, R.A., Rapaport, S.E. & Rao, L.V.M. (1988) Anti-prothrombin antibodies and the lupus anticoagulant. Blood, 72, 512 – 519. 10.1182/blood.V72.2.512.512 CASPubMedWeb of Science®Google Scholar Fowler, E. & Allen, R.H. (1962) Studies on the production of Wasserman reagent. Journal of Immunology, 88, 591 – 594. CASPubMedWeb of Science®Google Scholar Francis, R.B., McGehee, W.G. & Fernstein, D.I. (1988) Endothelial dependent fibrinolysis in subjects with the lupus anticoagulant and thrombosis. Thrombosis and Haemostasis, 59, 412 – 414. PubMedWeb of Science®Google Scholar Freyssinet, J.M., Wiesel, M.L., Gauchy, J., Boneu, B. & Cazenave, J.P. (1986) An IgM lupus anticoagulant that neutralizes the enhancing effect of phospholipid on purified thrombomodulin activity: a mechanism for thrombosis. Thrombosis and Haemostasis, 55, 309 – 312. CASPubMedWeb of Science®Google Scholar Gharavi, A.E., Mellors, R.C. & Elkon, K.B. (1987) MRL/lpr mice: a possible animal model for the anti-phospholipid syndrome (abstract). Arthritis and Rheumatism, 32, (Supplement), S121. Google Scholar Grobb, J.J. & Bonerandi, J.J. (1986) Cutaneous manifestations associated with the presence of the lupus anticoagulant. Journal of American Academy of Dermatology, 15, 211 – 219. 10.1016/S0190-9622(86)70159-X CASPubMedWeb of Science®Google Scholar Harris, E.N., Gharavi, A.E.M., Boey, M.L., Patel, B.M., Mackworth-Young, C.G., Loizou, S. & Hughes, G.R.V. (1983) Anti-cardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet, ii, 1211 – 1214. 10.1016/S0140-6736(83)91267-9 Google Scholar Harris, E.N., Gharavi, A.E., Loizou, S., Derue, G., Chan, J.K., et al (1985a) Crossreactivity of anti-phospholipid antibodies. Journal of Clinical and Laboratory Immunology, 16, 1 – 6. CASPubMedWeb of Science®Google Scholar Harris, E.N., Gharavi, A.E., Tincani, A., Chan, J.K.H., Englert, H., et al (1985b) Affinity purified anti-cardiolipin and anti-DNA antibodies. Journal of Clinical and Laboratory Immunology, 17, 155 – 162. CASPubMedWeb of Science®Google Scholar Harris, E.N., Asherson, R.A., Gharavi, A.E., Morgan, S.H., Derue, G. & Hughes, G.R.V. (1985c) Thrombocytopenia in SLE and related autoimmune disorders: association with anti-cardiolipin antibody. British Journal of Haematology, 59, 227 – 230. 10.1111/j.1365-2141.1985.tb02988.x CASPubMedWeb of Science®Google Scholar Harris, E.N., Gharavi, A.E. & Hughes, G.R.V. (1985d) Anti-phospholipid antibodies. Clinics in Rheumatic Diseases, 11, 591 – 609. PubMedWeb of Science®Google Scholar Haris, E.N., Chan, J.K.H., Asherson, R.A., Aber, V.R., Gharavi, A.E. & Hughes, G.R.V. (1986) Thrombosis, recurrent fetal loss, thrombocytopenia: predictive value of IgG anti-cardiolipin antibodies. Archives of Internal Medicine, 146, 2153 – 2159. CASPubMedWeb of Science®Google Scholar Harris, E.N., Gharavi, A.E., Patel, S.P. & Hughes, G.R.V. (1987a) Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986. Clinical and Experimental Immunology, 68, 215 – 222. CASPubMedWeb of Science®Google Scholar Harris, E.N., Asherson, R.A., Baguley, E., Ridley, M. & Hughes, G.R.V. (1987b) A standard anti-cardiolipin antibody test: usefulness in identification of the anti-phospholipid syndrome. (Abstract). Thrombosis and Haemostasis, 58, 392. Web of Science®Google Scholar Harris, E.N. (1988) Anti-cardiolipin test revisited. American Journal of Medicine, 85, 599 – 601. CASPubMedWeb of Science®Google Scholar Harris, E.N., Gharavi, A.E., Wasley, G.D. & Hughes, G.R.V. (1988) Use of an enzyme-linked immunosorbent assay and of inhibition studies to distinguish between antibodies to cardiolipin from patients with syphilis or autoimmune disorders. Journal of Infectious Diseases, 157, 23 – 31. 10.1093/infdis/157.1.23 CASPubMedWeb of Science®Google Scholar Harris, E.N. & Hughes, G.R.V. (1988) Thrombosis and miscarriages: the anti-phospholipid story. ISI Atlas of Science: Immunology, 1, 155 – 160. Web of Science®Google Scholar Harris, E.N. (1989) Standardization of the anti-cardiolipin test: report of an international cooperative study. The Kingston Anti-Phospholipid Study (KAPS) Group. (Abstract). Arthritis and Rheumatism, 32 (Supplement), S123. Google Scholar Hasselaar, P., Derksen, R.H.W.M., Blokzikl, L. & DeGroot, P.G. (1988) Thrombosis associated with anti-phospholipid antibodies cannot be explained by effects on endothelial cells and platelet prostanoid synthesis. Thrombosis and Haemostasis, 59, 80 – 85. CASPubMedWeb of Science®Google Scholar Hughes, G.R.V. (1983) Thrombosis, abortion, cerebral disease and the lupus anticoagulant. British Medical Journal, 287, 1088 – 1089. 10.1136/bmj.287.6399.1088 PubMedWeb of Science®Google Scholar Hughes, G.R.V. (1987) Systemic lupus erythematosus. Connective Tissue Diseases (ed. by G. R. V. Hughes), pp. 3 – 71. Blackwell Scientific Publications, Oxford . Web of Science®Google Scholar Hughes, G.R.V., Harris, E.N. & Gharavi, A.E. (1987) The anti-cardiolipin syndrome. Journal of Rheumatology, 13, 486 – 489. Web of Science®Google Scholar Inoue, G. & Nojima, S. (1969) Immunolochemical studies of phospholipids. IV. The reactives of antisera against natural cardiolipin and synthetic cardiolipin analogues-containing antigens. Chemistry and Physics of Lipids, 3, 70 – 77. 10.1016/0009-3084(69)90029-2 CASWeb of Science®Google Scholar Janoff, A.S. & Rauch, J. (1986) The structural specificity of anti-phospholipid antibodies in autoimmune disease. Chemistry and Physics of Lipids, 40, 315 – 322. 10.1016/0009-3084(86)90076-9 CASPubMedWeb of Science®Google Scholar Johansson, E.A. & Lassus, A. (1974) The occurrences of circulating anticoagulants in patients with syphilitic and biologically false positive anti-lipoidal antibodies. Annals of Clinical Research, 6, 105 – 108. CASPubMedWeb of Science®Google Scholar Johansson, E.A., Niemi, K.M. & Mustakallio, K.K. (1977) A peripheral vascular syndrome overlapping with systemic lupus erythematosus. Dermatologia, 155, 257 – 67. 10.1159/000250976 PubMedWeb of Science®Google Scholar Kataoka, T. & Nojima, S. (1970) Immunochemical studies of phospholipids. VI. Haptenic activity of phosphatidylinositol and the role of lecithin as an auxillary lipid. Journal of Immunology, 105, 502 – 511. CASPubMedWeb of Science®Google Scholar Kelsey, P.R., Stevenson, K.J. & Poller, L. (1984) The diagnosis of lupus anticoagulants by the activated partial thromboplastin time---the central role of phosphatidyl serine. Thrombosis and Haemostasis, 52, 172 – 176. CASPubMedWeb of Science®Google Scholar Koike, T., Sueshi, M., Funaki, H., Tomioka, H. & Yoshida, S. (1984) Anti-phospholipid antibodies and biological false positive serological test for syphilis in patients with systemic lupus erythematosus. Clinical and Experimental Immunology, 56, 193 – 199. CASPubMedWeb of Science®Google Scholar Laurell, A.B. & Nilsson, I.M. (1957) Hypergammaglobulinemia, circulating anticoagulant and biological false positive Wasserman reaction: a study of two cases. Journal of Laboratory and Clinical Medicine, 49, 694 – 707. CASPubMedWeb of Science®Google Scholar Levine, S.R. & Welsh, K.M.A. (1987) The spectrum of neurologic disease associated with anti-phospholipid antibodies. Google Scholar Lockshin, M.D., Druzin, M.L. & Quamar T. (1989) Prednisone does not prevent recurrent fetal death in women with anti-phospholipid antibody. American Journal of Obstetrics and Gynecology, 160, 439 – 443. 10.1016/0002-9378(89)90468-7 CASPubMedWeb of Science®Google Scholar Lockshin, M.D. (1987) Anti-cardiolipin antibody. Arthritis and Rheumatism, 30, 471 – 472. 10.1002/art.1780300420 CASPubMedWeb of Science®Google Scholar Lockshin, M.D., Quamar, T., Druzin, M. & Goei, S. (1987) Antibody to cardiolipin, lupus anticoagulant, and fetal death. Journal of Rheumatology, 14, 259 – 262. CASPubMedWeb of Science®Google Scholar Lockshin, M.D., Quamar, T., Levy, R.A. & Best, M.P. (1988) IgG but not IgM anti-phospholipid antibody binding is temperature dependent. Journal of Clinical Immunology, 8, 188 – 192. 10.1007/BF00917565 CASPubMedWeb of Science®Google Scholar Loizou, S., Byron, M.A., Englert, H.R., David, J., Hughes, G.R.V. & Walport, M.S. (1988) Association of quantitative anti-cardiolipin antibody levels with fetal loss and time of loss in systemic lupus erythematosus. Quarterly Journal of Medicine, 68, 525 – 531. PubMedWeb of Science®Google Scholar Loizou, S. & Walport, M.J. (1986) Antiphospholipid antibodies from patients with SLE and syphilis react homogeneously with different populations of phospholipids. (Abstract). British Journal of Rheumatology, 25, 9. Web of Science®Google Scholar Lubbe, W.F., Butler, W.S., Palmer, S.J. & Liggins, G.C. (1984) Lupus anticoagulant in pregnancy. British Journal of Obstetrics and Gynaecology, 91, 357 – 363. 10.1111/j.1471-0528.1984.tb05923.x CASPubMedWeb of Science®Google Scholar MacFarlane, M.G. & Gray, G.M. (1957) Composition of cardiolipin. Biochemical Journal, 67, 25 – 30. PubMedWeb of Science®Google Scholar Margolis, A., Jackson, D.P. & Ratnoff, O.D. (1961) Circulating anticoagulants: a study of 40 cases and a review of the literature. Medicine, 40, 145 – 202. PubMedWeb of Science®Google Scholar Mueh, J.R., Herbst, K.D. & Rapaport, S.I. (1980) Thrombosis in patients with the lupus anticoagulant. Annals of Internal Medicine, 92, 156 – 159. 10.7326/0003-4819-92-2-156 CASPubMedWeb of Science®Google Scholar Pangborn, M.D. (1941) A new serologically active phospholipid from beef heart. Proceedings of the Society for Experimental Biology and Medicine, 48, 484 – 486. 10.3181/00379727-48-13365P CASWeb of Science®Google Scholar Pengo, V., Heine, M.J., Thiagarajan, P. & Shapiro, S.S. (1987) Immunological specificity and mechanism of action of IgG lupus anticoagulants. Blood, 70, 69 – 76. CASPubMedWeb of Science®Google Scholar Pierangeli, S., Greenberg, R. & Harris, E.N. (1989) Determination of the calibration equation which achieves best accuracy and precision of the anti-cardiolipin assay. (Abstract). Arthritis and Rheumatism, 32 (Supplement), S123. Google Scholar Rauch, J., Tannenbaum, M., Tannenbaum, H., Ramelion, H., Cullis, P.R., Tilcock, C.P.S., Hope, M.J. & Janoff, A.S. (1986a) Human hybridoma lupus anticoagulants distinguish between bilayer and nonbilayer phase lipid systems. Journal of Biological Chemistry, 261, 9672 – 9677. CASPubMedWeb of Science®Google Scholar Rauch, J., Tannenbaum, H., Stollar, B.D. & Schwarz, R.S. (1986b) Monoclonal anti-cardiolipin antibodies bind DNA. European Journal of Immunology, 14, 529 – 534. 10.1002/eji.1830140609 CASPubMedWeb of Science®Google Scholar Rosove, M.H., Tabsh, K., Howard, P., Wasserstrum, N., Brinkman, C.R., Hahn, B.J. & Kalunian, K.C. (1987) Heparin therapy for prevention of fetal wastage of women with anti-cardiolipin antibodies and lupus anticoagulants. Blood, 70 (Supplement 1). 379a. Google Scholar Rustin, M.H.A., Bull, H.A., Machin, S.J., Isenberg, D.A., Smith, M.L. & Dowd, M. (1988) Effects of the lupus anticoagulant in patients with systemic lupus erythematosus on endothelial cell prostacyclin release and procoagulant activity. Journal of Investigational Dermatology, 90, 744 – 748. 10.1111/1523-1747.ep12560947 CASPubMedWeb of Science®Google Scholar Shapiro, S.S. & Thiagarajan, P. (1982) Lupus anticoagulant. Progress in Haemostatasis and Thrombosis, 6, 263 – 285. CASPubMedWeb of Science®Google Scholar Tan, E.M., Cohen, A.S., Fries, J.F., Masi, A.T., McShane, D.J., Rothfield, N.F., Schiller, J.G., Talal, N. & Winchester, R.J. (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis and Rheumatism, 25, 1271 – 1278. 10.1002/art.1780251101 CASPubMedGoogle Scholar Thiagarajan, P., Shapiro, S.S. & DeMarco, L. (1980) Monoclonal immunoglobulin M coagulation inhibitor with phospholipid specificity: mechanisms of a lupus anticoagulant. Journal of Clinical Investigation, 66, 397 – 405. 10.1172/JCI109869 CASPubMedWeb of Science®Google Scholar Triplett, D.A., Brandt, J.T., Kaczor, D. & Schaeffer, J. (1983) Laboratory diagnosis of lupus inhibitors: a comparison of the tissue thromboplastin inhibition procedure with a new platelet neutralization procedure. American Journal of Clinical Pathology, 79, 678 – 682. 10.1093/ajcp/79.6.678 CASPubMedWeb of Science®Google Scholar Triplett, D.A., Brandt, J.T., Musgrave, K.A. & Orr, C.A. (1988) Relationship between lupus anticoagulants and antibodies to phospholipids. Journal of the American Medical Association, 259, 550 – 554. PubMedWeb of Science®Google Scholar Triplett, D.A. & Brandt, J.T. (1988) Lupus anticoagulants: misnomer, pardox, riddle, epiphenomenon. Hematologic Pathology, 2, 121 – 143. CASPubMedGoogle Scholar Vermylen, J., Blockmans, D., Spitz, B. & Deckmyn, H. (1986) Thrombosis and immune disorders. Clinics in Haematology, 15, 1 – 19. Google Scholar Violi, F., Valesini, G., Ferro, D., Tincani, A., Balestrieri, G. & Balsano F. (1986) Anticoagulant activity of anti-cardiolipin antibodies. Thrombosis Research, 44, 543 – 547. 10.1016/0049-3848(86)90332-4 CASPubMedWeb of Science®Google Scholar Vismara, A., Meroni, P.L., Tincani, A., Harris, E.N., Barceliini, W., Brucato, A., et al (1988) Relationship between anti-cardiolipin and anti-endothelial cell antibodies in systemic lupus erythematosus. Clinical and Experimental Immunology, 74, 247 – 253. CASPubMedWeb of Science®Google Scholar Zarrabi, M.J., Zucker, S., Miller, F., Derman, R.M., Romano, G.S., Hartnett, J.A. & Varma, A.O. (1979) Immunologic and coagulation disorders in chlorpromazine treated patients. Annals of Internal Medicine, 91, 194 – 199. 10.7326/0003-4819-91-2-194 PubMedWeb of Science®Google Scholar Citing Literature Volume74, Issue1January 1990Pages 1-9 ReferencesRelatedInformation
Referência(s)